ARL13B and glioma: After single or repeated TTFields exposure, we plated cells in serum for 4 days, fixed, and immunostained for ARL13B alone or combined with pericentriolar material 1 (PCM1), another protein that clusters around the basal body and centrioles in glioma cells (29), or OFD1.